Abstract
Stringent regulation of the Wnt pathways components and modulators is indispensable for the restoration of tissue homeostasis and development. The Wnt/β-catenin-dependent canonical pathway is the most comprehensively introspected Wnt signaling pathway which relies upon Frizzled receptor activation and cytosolic β-catenin stabilization followed by their nuclear transport and subsequent transcriptional activation of multiple target genes to influence multiple cellular processes. The β-catenin-independent noncanonical pathway is the alternative Wnt signaling pathway which operates through either planar cell polarity [PCP] or calcium-signaling mechanism to modulate gene regulation. These pathways are highly branched and interconnected to modulate downstream mechanisms individually or in a concerted fashion. Aberrant Wnt signaling induced by genetic or epigenetic impetus leads to carcinogenesis and metastasis; evidently, several cancer types have depicted alterations in multiple Wnt pathway components to render them as potential targets for anticancer chemotherapy. Several small molecules and biologicals antagonizing the Wnt signaling are currently undergoing through different stages of clinical trial for customizing efficacious as well as safe anticancer therapeutics. However, the healthy cells are also susceptible to blockage of Wnt signaling pathways as potential side effects that pose inherent challenge to the strategy which needs to be dealt with utmost precaution. Cancer-specific Wnt markers and combination of multiple therapeutic strategies can overcome the limitation which lies at the focus of the ongoing oncotherapeutic introspections.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acebron SP, Karaulanov E, Berger BS, Huang YL, Niehrs C (2014) Mitotic wntsignaling promotes protein stabilization and regulates cell size. Mol Cell 54(4):663–674. https://doi.org/10.1016/j.molcel.2014.04.014
Arend RC, Londoño-Joshi AI, Straughn JM Jr, Buchsbaum DJ (2013) The Wnt/β-catenin pathway in ovarian cancer: a review. Gynecol Oncol 131(3):772–779. https://doi.org/10.1016/j.ygyno.2013.09.034
Arensman MD, Telesca D, Lay AR, Kershaw KM, Wu N, Donahue TR et al (2014) The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Mol Cancer Ther 13(10):2303–2314. https://doi.org/10.1158/1535-7163.MCT-13-1005
Arrigoni E, Del Re M, Galimberti S, Restante G, Rofi E, Crucitta S et al (2018) Concise review: chronic myeloid leukemia: stem cell niche and response to pharmacologic treatment. Stem Cells Transl Med 7(3):305–314. https://doi.org/10.1002/sctm.17-0175
Brown AM (2001) Wnt signaling in breast cancer: have we come full circle? Breast Cancer Res: BCR 3(6):351–355. https://doi.org/10.1186/bcr321
Buchert M, Athineos D, Abud HE, Burke ZD, Faux MC, Samuel MS et al (2010) Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet 6(1):e1000816. https://doi.org/10.1371/journal.pgen.1000816
Cadigan KM, Nusse R (1997) Wnt signaling: a common theme in animal development. Genes Dev 11(24):3286–3305. https://doi.org/10.1101/gad.11.24.3286
Carotenuto P, Fassan M, Pandolfo R, Lampis A, Vicentini C, Cascione L et al (2017) Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers. Gut 66(7):1268–1277. https://doi.org/10.1136/gutjnl-2016-312278
Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW et al (2009) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5(2):100–107. https://doi.org/10.1038/nchembio.137
Chiarini F, Paganelli F, Martelli AM, Evangelisti C (2020) The role played by Wnt/β-catenin signaling pathway in acute lymphoblastic leukemia. Int J Mol Sci 21(3):1098, 1–8. https://doi.org/10.3390/ijms21031098
Christie M, Jorissen RN, Mouradov D, Sakthianandeswaren A, Li S, Day F et al (2013) Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis. Oncogene 32(39):4675–4682. https://doi.org/10.1038/onc.2012.486
Cuilliere-Dartigues P, El-Bchiri J, Krimi A, Buhard O, Fontanges P, Fléjou JF, Hamelin R, Duval A (2006) TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene 25(32):4441–4448. https://doi.org/10.1038/sj.onc.1209471
Duchartre Y, Kim YM, Kahn M (2016) The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol 99:141–149. https://doi.org/10.1016/j.critrevonc.2015.12.005
Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, Ha JR, Kahn M (2004) A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A 101(34):12682–12687. https://doi.org/10.1073/pnas.0404875101
Fagotto F, Glück U, Gumbiner BM (1998) Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr Biol 8(4):181–190. https://doi.org/10.1016/s0960-9822(98)70082-x
Fernandes JC, Rodrigues Alves A, Machado-Neto JA, Scopim-Ribeiro R, Fenerich BA, da Silva FB et al (2017) IRS1/β-catenin axis is activated and induces MYC expression in acute lymphoblastic leukemia cells. J Cell Biochem 118(7):1774–1781. https://doi.org/10.1002/jcb.25845
Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J et al (2017) COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 45(D1):D777–D783. https://doi.org/10.1093/nar/gkw1121
Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlösser A et al (2010) Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia (New York, N.Y.) 12(4):326–335. https://doi.org/10.1593/neo.91972
Giles RH, van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653(1):1–24. https://doi.org/10.1016/s0304-419x(03)00005-2
Grassi S, Palumbo S, Mariotti V, Liberati D, Guerrini F, Ciabatti E et al (2019) The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia. Front Oncol 9:532, 1–12. https://doi.org/10.3389/fonc.2019.00532
Gregory MA, Phang TL, Neviani P, Alvarez-Calderon F, Eide CA, O’Hare T et al (2010) Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl. Cancer Cell 18(1):74–87. https://doi.org/10.1016/j.ccr.2010.04.025
Gruszka AM, Valli D, Alcalay M (2019) Wnt signalling in acute myeloid leukaemia. Cells 8(11):1403, 1–18. https://doi.org/10.3390/cells8111403
Guo X, Zhang R, Liu J, Li M, Song C, Dovat S et al (2015) Characterization of LEF1 high expression and novel mutations in adult acute lymphoblastic leukemia. PLoS One 10(5):e0125429. https://doi.org/10.1371/journal.pone.0125429
Habas R, Dawid IB (2005) Dishevelled and Wnt signaling: is the nucleus the final frontier? J Biol 4(1):2, 1–4. https://doi.org/10.1186/jbiol22
Hannoush RN (2015) Synthetic protein lipidation. Curr Opin Chem Biol 28:39–46. https://doi.org/10.1016/j.cbpa.2015.05.025
He X, Semenov M, Tamai K, Zeng X (2004) LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131(8):1663–1677. https://doi.org/10.1242/dev.01117
Heidel FH, Bullinger L, Feng Z, Wang Z, Neff TA, Stein L et al (2012) Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML. Cell Stem Cell 10(4):412–424. https://doi.org/10.1016/j.stem.2012.02.017
Hosseini V, Dani C, Geranmayeh MH, Mohammadzadeh F, Nazari Soltan Ahmad S, Darabi M (2018) Wnt lipidation: roles in trafficking, modulation, and function. J Cell Physiol 234:8040–8054. https://doi.org/10.1002/jcp.27570
Hwang SY, Deng X, Byun S, Lee C, Lee SJ, Suh H et al (2016) Direct targeting of β-catenin by a small molecule stimulates proteasomal degradation and suppresses oncogenic Wnt/β-catenin signaling. Cell Rep 16(1):28–36. https://doi.org/10.1016/j.celrep.2016.05.071
Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351(7):657–667. https://doi.org/10.1056/NEJMoa040258
Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC (2012) Structural basis of Wnt recognition by frizzled. Science 337(6090):59–64. https://doi.org/10.1126/science.1222879
Jung YS, Park JI (2020) Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex. Exp Mol Med 52(2):183–191. https://doi.org/10.1038/s12276-020-0380-6
Kim Y, Reifenberger G, Lu D, Endo T, Carson DA, Gast SM et al (2011) Influencing the Wnt signaling pathway in multiple myeloma. Anticancer Res 31(2):725–730
Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB et al (1991) Identification of FAP locus genes from chromosome 5q21. Science (New York, N.Y.) 253(5020):661–665. https://doi.org/10.1126/science.1651562
Komiya Y, Habas R (2008) Wnt signal transduction pathways. Organogenesis 4(2):68–75. https://doi.org/10.4161/org.4.2.5851
Kühnl A, Gökbuget N, Kaiser M, Schlee C, Stroux A, Burmeister T et al (2011) Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood 118(24):6362–6367. https://doi.org/10.1182/blood-2011-04-350850
Kurayoshi M, Yamamoto H, Izumi S, Kikuchi A (2007) Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling. Biochem J 402(3):515–523. https://doi.org/10.1042/bj20061476
Lento W, Congdon K, Voermans C, Kritzik M, Reya T (2013) Wnt signaling in normal and malignant hematopoiesis. Cold Spring Harb Perspect Biol 5(2):a008011. https://doi.org/10.1101/cshperspect.a008011
Lepourcelet M, Chen YN, France DS, Wang H, Crews P, Petersen F, Bruseo C, Wood AW, Shivdasani RA (2004) Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5(1):91–102. https://doi.org/10.1016/s1535-6108(03)00334-9
Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC (2000) Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 97(8):4262–4266. https://doi.org/10.1073/pnas.060025397
Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang T et al (2013) Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A 110(50):20224–20229. https://doi.org/10.1073/pnas.1314239110
Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20(1):781–810. https://doi.org/10.1146/annurev.cellbio.20.010403.113126
Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM, Kipps TJ et al (2004) Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 101(9):3118–3123. https://doi.org/10.1073/pnas.0308648100
Luis TC, Ichii M, Brugman MH, Kincade P, Staal FJ (2012) Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development. Leukemia 26(3):414–421. https://doi.org/10.1038/leu.2011.387
Lyou Y, Habowski AN, Chen GT, Waterman ML (2017) Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy. Br J Pharmacol 174(24):4589–4599. https://doi.org/10.1111/bph.13963
Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R et al (2009) Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci U S A 106(9):3396–3401. https://doi.org/10.1073/pnas.0900089106
Martin-Orozco E, Sanchez-Fernandez A, Ortiz-Parra I, Ayala-San Nicolas M (2019) WNT signaling in tumors: the way to evade drugs and immunity. Front Immunol 10:2854, 1–21. https://doi.org/10.3389/fimmu.2019.02854
Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A et al (2004) Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 127(4):1110–1122. https://doi.org/10.1053/j.gastro.2004.07.009
Meyers SL, O’Brien MT, Smith T, Dudley JP (1990) Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas. Cancer Res 50(18):5911–5918
Mikesch JH, Steffen B, Berdel WE, Serve H, Müller-Tidow C (2007) The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 21(8):1638–1647. https://doi.org/10.1038/sj.leu.2404732
Nguyen V, Hough R, Bernaudo S, Peng C (2019) Wnt/β-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis. J Ovarian Res 12(1):122, 1–17. https://doi.org/10.1186/s13048-019-0596-z
Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A et al (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (New York, N.Y.) 253(5020):665–669. https://doi.org/10.1126/science.1651563
Novellasdemunt L, Antas P, Li VS (2015) Targeting Wnt signaling in colorectal cancer. A review in the theme: cell Signaling: proteins, pathways and mechanisms. Am J Physiol Cell Physiol 309(8):C511–C521. https://doi.org/10.1152/ajpcell.00117.2015
Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15(1):28–32. https://doi.org/10.1038/sj.cr.7290260
Nusse R, van Ooyen A, Cox D, Fung YKT, Varmus H (1984) Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307(5947):131–136. https://doi.org/10.1038/307131a0
Nygren MK, Døsen G, Hystad ME, Stubberud H, Funderud S, Rian E (2007) Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol 136(3):400–413. https://doi.org/10.1111/j.1365-2141.2006.06442.x
Nygren MK, Døsen-Dahl G, Stubberud H, Wälchli S, Munthe E, Rian E (2009) beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells. Exp Hematol 37(2):225–233. https://doi.org/10.1016/j.exphem.2008.10.007
Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin J et al (2019) Wnt-β-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol 16(2):121–136. https://doi.org/10.1038/s41575-018-0075-9
Petropoulos K, Arseni N, Schessl C, Stadler CR, Rawat VP, Deshpande AJ et al (2008) A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis. J Exp Med 205(3):515–522. https://doi.org/10.1084/jem.20071875
Pohl SG, Brook N, Agostino M, Arfuso F, Kumar AP, Dharmarajan A (2017) Wnt signaling in triple-negative breast cancer. Oncogenesis 6(4):e310. https://doi.org/10.1038/oncsis.2017.14
Polakis P (2012) Wnt signaling in cancer. Cold Spring Harb Perspect Biol 4(5):a008052. https://doi.org/10.1101/cshperspect.a008052
Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC (2009) Multiple myeloma. Lancet (London, England) 374(9686):324–339. https://doi.org/10.1016/S0140-6736(09)60221-X
Rao TP, Kühl M (2010) An updated overview on Wnt signaling pathways: a prelude for more. Circ Res 106(12):1798–1806. https://doi.org/10.1161/CIRCRESAHA.110.219840
Rapp J, Jaromi L, Kvell K, Miskei G, Pongracz JE (2017) WNT signaling – lung cancer is no exception. Respir Res 18(1):167, 1–16. https://doi.org/10.1186/s12931-017-0650-6
Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R (1987) The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50(4):649–657. https://doi.org/10.1016/0092-8674(87)90038-9
Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24(3):245–250. https://doi.org/10.1038/73448
Saultz JN, Garzon R (2016) Acute myeloid leukemia: a concise review. J Clin Med 5(3):33. https://doi.org/10.3390/jcm5030033
Schatoff EM, Leach BI, Dow LE (2017) Wnt signaling and colorectal cancer. Curr Colorectal Cancer Rep 13(2):101–110. https://doi.org/10.1007/s11888-017-0354-9
Schulte G, Bryja V (2007) The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol Sci 28(10):518–525. https://doi.org/10.1016/j.tips.2007.09.001
Spaan I, Raymakers RA, van de Stolpe A, Peperzak V (2018) Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential. J Hematol Oncol 11(1):67, 1–18. https://doi.org/10.1186/s13045-018-0615-3
Staal FJ, Famili F, Garcia Perez L, Pike-Overzet K (2016) Aberrant Wnt signaling in leukemia. Cancers 8(9):78, 1–15. https://doi.org/10.3390/cancers8090078
Stewart DJ (2014) Wnt signaling pathway in non-small cell lung cancer. J Nat Cancer Ins 106(1):djt356. https://doi.org/10.1093/jnci/djt356
Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R, Yokota J (2001) Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 30(3):316–321. https://doi.org/10.1002/1098-2264(2000)9999:9999<::aid-gcc1097>3.0.co;2-9
Takigawa Y, Brown AM (2008) Wnt signaling in liver cancer. Curr Drug Targets 9(11):1013–1024. https://doi.org/10.2174/138945008786786127
Tennis M, Van Scoyk M, Winn RA (2007) Role of the wnt signaling pathway and lung cancer. J Thorac Oncol 2(10):889–892. https://doi.org/10.1097/JTO.0b013e318153fdb1
van Andel H, Kocemba KA, Spaargaren M, Pals ST (2019) Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia 33(5):1063–1075. https://doi.org/10.1038/s41375-019-0404-1
van Schie EH, van Amerongen R (2020) Aberrant WNT/CTNNB1 signaling as a therapeutic target in human breast cancer: weighing the evidence. Front Cell Dev Biol 8:25, 1–14. https://doi.org/10.3389/fcell.2020.00025
Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA (2000) Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19(4):498–504. https://doi.org/10.1038/sj.onc.1203356
Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59–88. https://doi.org/10.1146/annurev.cellbio.14.1.59
Wu R, Zhai Y, Fearon ER, Cho KR (2001) Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61(22):8247–8255
Yin P, Wang W, Zhang Z, Bai Y, Gao J, Zhao C (2018) Wnt signaling in human and mouse breast cancer: focusing on Wnt ligands, receptors and antagonists. Cancer Sci 109(11):3368–3375. https://doi.org/10.1111/cas.13771
Yu S, Zhou X, Steinke FC, Liu C, Chen SC, Zagorodna O et al (2012) The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity 37(5):813–826. https://doi.org/10.1016/j.immuni.2012.08.009
Yu J, Chia J, Canning CA, Jones CM, Bard FA, Virshup DM (2014) WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. Dev Cell 29(3):277–291. https://doi.org/10.1016/j.devcel.2014.03.016
Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36(11):1461–1473. https://doi.org/10.1038/onc.2016.304
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Prasad, M., Ghosh, M., Kumar, R., Buragohain, L., Kumari, A., Prasad, G. (2022). Wnt Signaling in Cancer. In: Chakraborti, S., Ray, B.K., Roychoudhury, S. (eds) Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-15-9411-3_81
Download citation
DOI: https://doi.org/10.1007/978-981-15-9411-3_81
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-9410-6
Online ISBN: 978-981-15-9411-3
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences